Search Results
Results found for "Eric Johansen"
- How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs
Eric Trinquet, a veteran innovator behind functional GPCR assays like HTRF and IP-One, believes rigid “You can try, try, try—and fail, fail, fail,” Eric says. Instead of chasing linear progress, Eric encourages young scientists to stay playful longer—embracing Eric and his team rejected the calcium route entirely. Eric is clear: real innovation requires real partnerships.
- Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc. has...
November 2021 Addex's strategic partner The Janssen Pharmaceutical Companies of Johnson & Johnson, Inc today announced that Janssen Pharmaceuticals, Inc., part of the Janssen Pharmaceutical Companies of Johnson & Johnson, has successfully completed Phase 1 studies in Japan with JNJ-40411813 (ADX71149).
- Michel Bouvier appointed Knight of the Ordre national du Québec
June 2022 "Published on juin 22, 2022 On June 22, 2022, Michel Bouvier, Chief Executive Officer of IRIC
- Novo Nordisk moves to strengthen obesity efforts
year, Novo Nordisk is strengthening its position in the obesity space through a collaboration with EraCal Under the joint research plan, the Danish giant will work with EraCal to identify novel drug targets Although specific details of the collaboration are yet to be released, EraCal has confirmed that the
- Dr. GPCR Spotlights Revvity’s pHSense™ Internalization Tools
Eric Trinquet, Director of Research and Development at Revvity. Eric Trinquet to the Dr. precision reagents and validated assay platforms. 🔍 Learn More → Listen to the Podcast with Revvity’s Eric
- The Truth About GPCR Product Launches: Years in the Making
Exploring the foundational stages of scientific breakthroughs with Eric Trinquet, highlighting that true Eric Trinquet shares what it really takes to bring a product to life—from sketch to shelf. Eric Trinquet joined Cisbio in the early 2000s, working on what would become HTRF—Homogeneous Time-Resolved Eric Trinquet The Real Work Starts Before the Lab What most scientists don’t see is how long a product
- Innovative Data-Driven Solutions: The pHSense Revolution
Eric Trinquet, that moment arrived when his team successfully tracked GPCR internalization in native That’s the promise of pHSense, a groundbreaking reagent developed by Eric Trinquet and his team at Revvity Eric Trinquet.
- Understanding Enzyme Inhibition In GPCR Discovery Programs
Eric Trinquet, the scientist behind IP-One, Tag-lite, and now pHSense, challenges conventional scientific From failing fast to embracing serendipity, Eric shares the mindset (and messy origin stories) that shaped
- How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights
Eric Trinquet shares in a special Dr.
- Assay Volume Control: Your GPCR Drug Discovery Power Lever
Eric Trinquet traces how a series of bold pivots—from Cisbio’s HTRF platform to IP-One and now pHSense—reshaped
- 📰 GPCR Weekly News, January 16 to 22, 2023
Addex Provides Corporate Update And Financial Guidance Structure Therapeutics Appoints Industry Leaders Eric
- Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization
Eric Trinquet and his team at Revvity, that moment came when they watched GPCRs internalize in native
- GPCR Buzz of the Week | Sep 23 - 29, 2024
We're sending you all the good vibes and a sprinkle of birthday magic for an epic celebration! 🚀🎉 Kilian Roßmann , Joshua Levitz , Johannes Broichhagen for their excellent work on Deuteration
- Ode to GPCRs
employed in GPCRs mediated signal transduction.[47] The 2000 Nobel Prize in Physiology or Medicine went to Eric Eric R.
- GPCR Therapeutics welcomes Dr. Ed Brennan as their new Vice President, Head of Clinical Development
Previous companies worked at include OrthoBiotech (OBI), a division of Johnson & Johnson and GlaxoSmithKline
- How System-Level GPCR Thinking Prevents Discovery Failures
Johannes Broichhagen Reliable imaging tools change how researchers see receptor behavior. Johannes Broichhagen explains how next-generation fluorescent probes—designed with precise synthetic
- Profiling Immune Cell and Platelet Transcriptomes
A study published in Scientific Data by Arne Hansen et a l has introduced a sensitive method for detecting
- How a Failed Experiment Created a Powerful GPCR Imaging Tool
#177 The Experiment That Was Never Meant to Succeed When David Hodson’s lab teamed up with chemist Johannes
- From Farm Fields to GPCR Discovery, GLP-1 and GIP
Johannes Broichhagen - aka JB — which, amusingly, began when Hodson opened the door wearing cleaning
- GPCR Binding Affinity Experiments: Interpreting Data With Confidence as We Head Into 2026
Maria Majellaro, Johannes Broichhagen, and David Hodson discuss GLP-1 receptor probes, fluorescence-based
- When the Islet Lit Up: Advancing GPCR Imaging in Native Tissue
Johannes “JB” Broichhagen trained as a synthetic chemist — someone who trusted carbon–carbon bonds far
- 🤯Mind-blowing GPCR Scoops! Discover the Latest Breakthroughs! ⦿ Nov 18 - 24, 2024
ductal adenocarcinoma, β-blockers and antihistamines: A clinical trial is needed Jillian G Baker , Erica
- 📰 GPCR Weekly News, November 20 to 26, 2023
Showcases Innovative AI-Driven Drug Design at BRIC AI 2023 Workshop Salipro Biotech AB Celebrates Milestones
- 📰 GPCR Weekly News, January 1 to 7, 2024
Anthony Johnson as President/CEO! Save the dates: February 8 - 29: Join Dr.
- Hop in the Time Machine with GPCR: Unraveling the Future of Research! ⦿ Nov 24 - Dec 1, 2024
interrogation of GPCR co-internalization Kilian Roßmann , Ramona Birke , Joshua Levitz , Ben Jones , Johannes
- Structural landscape of the Chemokine Receptor system
stability of the salt bridge depends on the position of NH2, which is most stable at position 1 (Wasilko, Johnson
- The Perils and Guardrails of Modifying Signalling Proteins in Bioassays
DiMasi JA, Grabowski HG, Hansen RW.

















